Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Quince Therapeutics Inc., 3 years.
Quince Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 18, 2026 | Exelixis Inc. | Open-market sale | −34,901 | $50.00 | $1,745,050 |
| May 15, 2026 | Exelixis Inc. | Shares withheld for tax | −40,892 | $51.10 | $2,089,581 |
| Feb 26, 2026 | Exelixis Inc. | Grant or award | +52,018 | — | — |
| Feb 17, 2026 | Exelixis Inc. | Open-market sale | −30,617 | $43.67 | $1,337,044 |
| Feb 15, 2026 | Exelixis Inc. | Shares withheld for tax | −35,870 | $43.92 | $1,575,410 |
| Feb 13, 2026 | Exelixis Inc. | Open-market sale | −34,278 | $43.00 | $1,473,954 |
| Jan 15, 2026 | Exelixis Inc. | Grant or award | +149,474 | — | — |
| Jan 15, 2026 | Exelixis Inc. | Shares withheld for tax | −40,459 | $45.23 | $1,829,961 |
| May 16, 2025 | Exelixis Inc. | Option exercise | +100,000 | $18.80 | $1,880,000 |
| May 16, 2025 | Exelixis Inc. | Open-market sale | −100,000 | $46.00 | $4,600,000 |
| May 15, 2025 | Exelixis Inc. | Shares withheld for tax | −41,422 | $44.65 | $1,849,492 |
| Mar 31, 2025 | Exelixis Inc. | Grant or award | +170,009 | — | — |
| Feb 26, 2025 | Exelixis Inc. | Grant or award | +59,648 | — | — |
| Feb 24, 2025 | Exelixis Inc. | Option exercise | +29,314 | $18.80 | $551,103 |
| Feb 24, 2025 | Exelixis Inc. | Open-market sale | −29,314 | $36.14 | $1,059,408 |
Questions about Christopher J. Senner
What boards is Christopher J. Senner on?
Christopher J. Senner sits on the board of Quince Therapeutics Inc.
How long has Christopher J. Senner served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.